drugset / Trial / NCT06915246

A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma

NCT06915246

Phase 2 Recruiting 49 enrolled VIVUS LLC
RandomizedParallel-groupOpen-labelTreatment

Summary

A phase 2 multicenter study of VI-0609 vs BiCNU in the BEAM high-intensity conditioning regimen for AHCT in subjects with lymphomas.

Timeline

Start
2025-03-12
Primary completion
2027-03-31
Completion
2027-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject carmustine Small molecule